Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Kim

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed GlioblastomaMichelle M Kim, Yilun Sun, Madhava P Aryal, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
The Lancet. Oncology|August 23, 2015
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 studyTony Reid, Bryan Oronsky, Jan Scicinski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2025
Parotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical TrialKyle Wang, Allison M Deal, Colette J Shen, et al.
Nature Communications|March 31, 2026
Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media componentsNeal I Callaghan, Lauren J Durland, Wenliang Chen, et al.
Practical Radiation Oncology|May 9, 2022
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice GuidelineVinai Gondi, Glenn Bauman, Lisa Bradfield, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Practical Radiation Oncology|June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice GuidelineDebra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed GlioblastomaMichelle M Kim, Yilun Sun, Madhava P Aryal, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
The Lancet. Oncology|August 23, 2015
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 studyTony Reid, Bryan Oronsky, Jan Scicinski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2025
Parotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical TrialKyle Wang, Allison M Deal, Colette J Shen, et al.
Nature Communications|March 31, 2026
Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media componentsNeal I Callaghan, Lauren J Durland, Wenliang Chen, et al.
Practical Radiation Oncology|May 9, 2022
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice GuidelineVinai Gondi, Glenn Bauman, Lisa Bradfield, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Practical Radiation Oncology|June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice GuidelineDebra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
Pageof 13